浏览标题索引

标题 文件
卷 17, 编号 3 (2015) Pamyati Gianni Bonadonna
- -.
卷 27, 编号 3 (2025) In memory of Professor Evgeny Alexandrovich Osmanov PDF
(Rus)
Editorial T.
卷 12, 编号 3 (2010) Panitumumab v terapii metastaticheskogokolorektal'nogo raka: dannye klinicheskikhissledovaniy, problema kozhnoy toksichnosti
Artamonova E.
卷 4, 编号 4 (2002) Parametry serdechno-dykhatel'nogo sinkhronizma i prognoz razvitiya onkologicheskogo zabolevaniya
Arkad'eva T., Ostrizhnaya N.
卷 15, 编号 1 (2013) Pathogenesis and correction of anemic syndrome in lymphoproliferative disorders patients
Romanenko N.
卷 25, 编号 4 (2023) Patient resource to improve the effectiveness of oncological care for the population PDF
(Rus)
Kozlov V., Samsonov I., Mushnikov D.
卷 8, 编号 2 (2006) Pemetreksed (alimta)
Tyulyandin S.
卷 22, 编号 2 (2020) First-line therapy of indolent non-Hodgkin’s lymphoma in routine clinical practice PDF
(Rus)
Babicheva L., Poddubnaya I.
卷 10, 编号 3 (2008) Pervichnaya mediastinal'nayaV-krupnokletochnaya limfoma: diagnostika, klinicheskaya kartina i lechenie
Tumyan G., Kovrigina A., Kichigina M., Sorokin E., Bykov D., Kondrat'eva T., Probatova N., Trofimova O., Kolomeytsev O., Poddubnaya I., Tupitsyn N., Larionova V., Osmanov D.
卷 25, 编号 3 (2023) Initial treatment for adults with advanced kidney cancer (renal cell carcinoma) [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review] PDF
(Rus)
Melnikov V.
卷 5, 编号 1 (2003) Pervichno-mnozhestvennye zlokachestvennye opukholi s porazheniem sosudistoy obolochki glaza
Lerner M.
卷 16, 编号 2 (2014) Second primary cancer in patients with head and neck squamous cell carcinoma (review of the literature)
Agabekyan G., Kropotov M., Saprina O., Stelmakh D., Park M.
卷 3, 编号 4 (2001) Pervichnye MALT-limfomy zheludka u bol'nykh pozhilogo vozrasta
Moskalenko O., Osmanov D., Probatova N., Kokosadze N., Sholokhova E., Kovrigina A., Kuvshinov Y., Poddubnyy B., Poddubnaya I.
卷 8, 编号 4 (2006) Pervichnye limfomy kozhi: diagnostika i lechenie
Belousova I., Krivolapov Y.
卷 13, 编号 4 (2011) Pervichnye nekhodzhkinskielimfomy kostey
Sotnikova O., Sorokin E., Kovrigina A., Bykov D., Osmanov E., Poddubnaya I.
卷 26, 编号 4 (2024) First results of a multicenter, non-randomized, prospective phase II study of the efficacy and safety of induction therapy with pembrolizumab, cisplatin, and 5-fluorouracil in patients with unresectable squamous cell carcinoma of the oropharynx, hypopharynx and larynx PDF
(Rus)
Stativko O., Pokataev I., Kravtsov S., Zhukova L., Stroyakovskiy D., Sabitov E., Kuzmina E., Feoktistova P., Antonova T., Lyadova M., Nosova M., Sydykova R., Lisitsyna K., Strelnikova T., Alizade G., Parts S., Dolov M., Tedeeva A., Galkin V.
卷 20, 编号 2 (2018) The first results of the national programme for the diagnosis and treatment of HER2-positive breast cancer in Turkmenistan PDF
(Rus)
Berdimyradova M., Khadjiev S., Khommadova D., Polatova G., Kakajanova A., Batyrov C., Penayev D., Agayeva B., Annaberdiyeva G.
卷 16, 编号 2 (2014) First results of the Russian multicenter epidemiology project on the malignant gliomas
Smolin A., Bekyashev A., Kobyakov G., Sharabura T., Mufazalov F., Kanischeva N., Bumagina V.
卷 26, 编号 4 (2024) The first experience in Russia of applying a tumor differentiation protocol in a patient with progressive, radioiodine-refractory BRAF-positive papillary thyroid cancer. Case report PDF
(Rus)
Slashchuk K., Reinberg M., Serzhenko S., Sheremeta M., Nikiforovich P.
卷 20, 编号 3 (2018) The first experience of immunotherapy application of ipilimumab in combination with chemotherapy of small-cell lung cancer in the Russian population. Analysis of the combined data of two centers, participating in the multicenter randomized phase III study СА 184-156 PDF
(Rus)
Kuzminov A., Gorbunova V., Poddubskaya E., Bagrova S., Baranova M., Laktionov K.
卷 12, 编号 2 (2010) Pervyy opyt luchevogo lecheniyaploskokletochnogo raka orofaringeal'noyzony s radiomodifikatsiey tsetuksimabomi tsisplatinom
Boyko A., Bolotina L., Chernichenko A., Gevorkov A., Smirnov A.
卷 10, 编号 3 (2008) Pervyy opyt primeneniya alemtuzumaba u bol'nykh khronicheskim limfoleykozom,refrakternykh k fludarabinsoderzhashchim programmam khimioterapii
Zagoskina T., Malykh O., Khorobrykh M., Dem'yanova V., Isaeva N., Grishina I.
卷 26, 编号 3 (2024) Tolerability of perioperative chemotherapy for gastric cancer in real clinical practice PDF
(Rus)
Fedorinov D., Lyadova M., Lyadov V.
卷 26, 编号 3 (2024) Perioperative chemotherapy and morphological response in the treatment of gastric cancer: A retrospective study PDF
(Rus)
Kiselev N., Klimin S., Kolesnik Y., Kokorin R., Ashimov E., Elagina V., Shumskaya I., Zagainov V., Gamayunov S.
卷 20, 编号 2 (2018) Perioperative chemotherapy for gastric cancer: the current state PDF
(Rus)
Lyadov V., Pardabekova O., Lyadova M.
卷 26, 编号 4 (2024) Peritoneal lymphomatosis as the only manifestation of diffuse B-cell large cell lymphoma: A clinical case PDF
(Rus)
Ognerubov N., Antipova T., Poddubnaya I.
卷 3, 编号 2 (2001) Perifericheskaya neyrotoksichnost' taksotera
Shakirova I., Lebedeva L., Borisova T., Meshcheryakov A., Setdikov R., Gutorov S.
卷 22, 编号 4 (2020) Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation (Russian Translation of Cochrane Plain Language Summary – PLS) PDF
(Rus)
Alexandrova E.
卷 16, 编号 1 (2014) Low-risk persistent trophoblastic disease: results of treatment
Tikhonovskaya M., Meshcheryakova L., Kuznetcov V.
卷 16, 编号 3 (2014) Personalized approach to HER2-positive advanced breast cancertherapy
Stenina M.
卷 5, 编号 2 (2003) Perspektiva razvitiya khimioterapii s izucheniem etnicheskogo i individual'nogo polimorfizma sistemy tsitokhromov R-450 v Respublike Sakha (Yakutiya)
Ivanova F.
卷 23, 编号 1 (2021) Opportunities for metastatic triple negative breast cancer therapy PDF
(Rus)
Ganshina I., Gordeeva O., Manukyan M.
卷 27, 编号 2 (2025) Prospects for the use of big data, artificial intelligence, machine learning, neural networks, and deep learning in the diagnosis and treatment of malignant tumors of the genitourinary system: a review PDF
(Rus)
Khachaturyan A.
卷 9, 编号 3 (2007) Perspektivy ispol'zovaniya Tsetuksimaba pri zlokachestvennykh opukholyakh tolstoy kishki i opukholyakh golovy i shei
Khokhlova S., Romanov I., Gorbunova V., Matyakin E.
卷 24, 编号 2 (2022) Prospects for the treatment of neurofibromatosis type 1: A review PDF
(Rus)
Mustafin R.
卷 27, 编号 3 (2025) Prospects for molecular profiling in bladder cancer stratification and treatment. A review PDF
(Rus)
Lyubchenko L., Сhernavina K., Ghazaryan K., Zaborskiy I., Karyakin O.
卷 16, 编号 3 (2014) Prospects for revision of the histological classification of neuroendocrine tumorsBased on the materials of 11-th Annual European Neuroendocrine Tumor Society Conference
Gurevich L., Delectorskaya V.
卷 14, 编号 3 (2012) Perspektivy primeneniya ademetionina v komplekse intensivnoy terapii bol'nykh s ostroy pechenochnoy nedostatochnost'yu: vzglyad reanimatologa
Gromova E.
卷 22, 编号 2 (2020) Prospects of eribulin administration for patients with HR-positive HER2-negative metastatic breast cancer after progression on CDK4/6 Inhibitors: theoretical background and first experience PDF
(Rus)
PDF
(Eng)
Kolyadina I., Ganshina I., Kuzmicheva S., Tekeeva A., Kolokolov J., Volkonskii M., Poddubnaya I.
卷 22, 编号 3 (2020) Prospects for the development of adjuvant therapy for non-small cell lung cancer PDF
(Rus)
Laktionov K., Kazakov A., Reutova E., Ardzinba M., Arzumanian A.
卷 3, 编号 3 (2001) Perspektivy khimioterapii raka molochnoy zhelezy: vozmozhnosti gemzara po materialam ASCO 2001 g
Makarenko N.
卷 23, 编号 1 (2021) Piqray – basic questions at the start: whom to test? whom to treat? how to treat? Event review of the satellite symposium. RUSSCO Big Conference «Breast Cancer» (online). January 29th, 2021 PDF
(Rus)
Board E.
卷 25, 编号 3 (2023) Esophageal anastomosis: experience of open surgery and modern possibilities of video endoscopic technologies. A review PDF
(Rus)
Nered S.
卷 25, 编号 2 (2023) Squamous cell carcinoma of the skin after cardiac transplantation: a clinical case PDF
(Rus)
Ognerubov N., Ognerubova M.
卷 22, 编号 4 (2020) Squamous cell breast cancer: description of a rare clinical case PDF
(Rus)
Zikiryakhodjaev A., Khakimova S., Rasskazova E., Saribekian E., Omarova D., Surkova V., Khakimova G.
卷 20, 编号 4 (2018) Pneumonectomy with carinal resection in patients with non-small cell lung cancer: short and long-term results PDF
(Rus)
Dadyev I., Davydov M., Abdullaev A., Kulik I., Ambalova Z., Akhmedov P., Anokhin A., Karasheva B.
卷 27, 编号 3 (2025) Following in the footsteps of ASCO-2025: TOP studies that will change the treatment strategy of advanced HR+ and HER2+ breast cancer. A review PDF
(Rus)
Kolyadina I., Poddubnaya I.
卷 25, 编号 1 (2023) Following in the footsteps of SABCS 2022: top 12 advanced breast cancer studies that could change our clinical practice: A review PDF
(Rus)
Kolyadina I.
卷 25, 编号 1 (2023) Following in the footsteps of SABCS 2022: top 16 early breast cancer studies that could change our clinical practice: A review PDF
(Rus)
Kolyadina I.
卷 26, 编号 3 (2024) Increasing the effectiveness of total-skin electron beam therapy by reducing the manifestations of radiation dermatitis in patients with primary lymphomas. A comparative randomized prospective study PDF
(Rus)
Zelianina M., Vinogradova Y., Zaslavskiy D., Gilvanova E., Ilyin N.
卷 24, 编号 1 (2022) Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer (Russian Translation of Cochrane Plain Language Summary) PDF
(Rus)
Staroverova T.
卷 6, 编号 3 (2004) Podavlenie superekspressii protoonkogena ornitindekarboksilazy v adenomatoznykh polipakh tolstoy kishki pri naznachenii bol'nym vysokikh doz folievoy kisloty
Draudin-Krylenko V., Mazurov S., Levchuk A., Orlov E., Poddubnyy B., Bukin Y.
卷 14, 编号 1 (2012) Podvedeny itogi I Vserossiyskoy premiiv oblasti onkologii «IN VITA VERITAS»
- -.
卷 26, 编号 3 (2024) Preparing a patient with bowel cancer for surgery with multiple interventions (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review) PDF
(Rus)
Editorial B.
卷 14, 编号 3 (2012) Podderzhivayushchaya terapiya nemelkokletochnogo raka legkogo
Gutorov S., Borisova E.
卷 14, 编号 3 (2012) Podderzhivayushchaya terapiya pri metastaticheskom kolorektal'nom rake: odin iz variantov vybora ili novyy standart lecheniya?
Artamonova E.
卷 18, 编号 2 (2016) Supportive therapy for ovarian cancer PDF
(Rus)
Pokataev I., Tyulyandin S.
卷 23, 编号 3 (2021) Telephone interventions for symptom management in adults with cancer (Russian Translation of Cochrane Plain Language Summary – PLS) PDF
(Rus)
Lapshina D.
卷 3, 编号 3 (2001) Podkhody k profilaktike khirurgicheskoy ranevoy infektsii u onkologicheskikh bol'nykh
Petukhova I., Dmitrieva N., Varlan G.
卷 26, 编号 4 (2024) Approaches to therapy of relapsed and refractory forms of anaplastic large cell lymphoma in children and adolescents: A review PDF
(Rus)
Volkova A.
卷 6, 编号 1 (2004) Pozdnee metastazirovanie granulezokletochnoy opukholi yaichnika
Ivanov Y., Solov'ev N., Markina R., Stepanov V., Sokolova N.
卷 8, 编号 1 (2006) Pozdnie oslozhneniya terapii bol'nykh limfomoy Khodzhkina
Demina E., Pylova I., Shmakov R., Perilova E.
卷 2, 编号 2 (2000) Poliklinicheskiy opyt primeneniya arimideksa u bol'nykh rasprostranennym rakom molochnoy zhelezy v menopauze
Potapov S., Kapitonova E.
卷 22, 编号 3 (2020) Polyploid giant cancer cells and their role in the formation of resistance to therapeutic treatment PDF
(Rus)
Vartanyan N., Pinevich A., Bode I., Samoylovich M.
卷 24, 编号 2 (2022) Benefits of capecitabine in hormone receptor-positive compared to hormone receptor-negative breast cancer PDF
(Rus)
Evdokimova Y.
卷 25, 编号 2 (2023) Pomalidomide in the management of relapsed/refractory multiple myeloma: A review PDF
(Rus)
Semochkin S.
卷 26, 编号 2 (2024) Do cancer vaccines help people with advanced non-small cell lung cancer? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review) PDF
(Rus)
Editorial B.
卷 15, 编号 2 (2013) The concept of resectability in the treatment of colorectal cancer liver metastases: the present notion
Bagmet N., Bedzhanyan A., Polishchuk L., Sekacheva M., Shatveryan G., Skipenko O.
卷 17, 编号 1 (2015) A population-based portrait of breast cancer in russia: a cancer register-based analysis in russian
Poddubnaya I., Kolyadina I., Kalashnikov N., Borisov D., Makarova M.
卷 6, 编号 4 (2004) Populyatsionnyy rakovyy registr kak osnova organizatsii tselevykh (skriningovykh) meditsinskikh osmotrov i kontrolya polnoty registratsii zabolevaniy
Cherenkov V., Loktionova M., Chistyakova T.
卷 16, 编号 1 (2014) Renal involvement in children with non-Hodgkin lymphomas
Valiev T., Panferova T., Koshechkina N., Zakharova E., Mikhailova E., Kaminskaya I.
卷 9, 编号 3 (2007) Postmastektomicheskaya limfedema verkhnikh konechnostey: vozmozhnosti konservativnogo lecheniya
Myasnikova M.
卷 20, 编号 2 (2018) The post-mastectomy syndrome: the secondary lympedema after the combined treatment of breast cancer (the literature review and own results) PDF
(Rus)
Stepanova A., Merzlyakova A., Khulamhanova M., Trofimova O.
卷 21, 编号 1 (2019) The potential use of oncolytic viruses in breast cancer: historical aspects and future prospects (literature review) PDF
(Rus)
Morozov D., Kolyadina I., Poddubnaya I., Chumakov P., Ilinskaya G., Bokhian V., Sopova M.
卷 21, 编号 2 (2019) The potential of using eribulin in patients with breast cancer, associated with brain metastasis: the scientific background and the Russian clinical experience PDF
(Rus)
Kolyadina I., Bulavina I., Petkau V., Strakhova N., Gorbunova V., Kovalenko E., Manziuk L., Artamonova E., Zhukova L., Bolotina L., Gan'shina I., Semiglazova T., Manikhas A., Raevskaia N., Itkin I., Khokhlova S., Filonenko D., Gol'dberg V., Popova N., Ponomarenko D., Shikina V., Vladimirova L., Tikhanovskaia N., Karabina E., Mukhametshina G., Khasanova A., Safina S., Shaidorov M., Orlov A., Kostalanova I., Levchenko N., Osipov M., Karandeeva T., Evstigneeva I., Chernov I., Kolokolov D., Povyshev A., Shatokhina A., Cherniakova E., Shkodenko O., Kuz'mina E.
卷 5, 编号 3 (2003) Pravitel'stvo Rossiyskoy Federatsii Rasporyazhenie20 marta 2003 g.№357-R
- -.
卷 8, 编号 3 (2006) Preventivnaya limfodissektsiya pri rake gortani i gortanoglotki T3-4N0M0
Boykov V.
卷 23, 编号 4 (2021) Preliminary assessment of the possibility of using urokinase uPA and urokinase receptor uPAR as universal diagnostic criteria in patients with colorectal and gastric adenocarcinoma PDF
(Rus)
Klimovich P., Rubina K., Mironov N., Kakotkin V., Oleynikova N., Mal`kov P., Kubyshkin V., Galliamov E., Agapov M., Semina E.
卷 10, 编号 1 (2008) Predvaritel'nye rezul'taty induktsionnoy khimioterapii s paklitakselom pri mestnorasprostranennom rake sheyki matki
Morkhov K., Kuznetsov V., Lebedev A., Nechushkina V., Zakharova T., Tyulyandin S.
卷 15, 编号 1 (2013) Preliminary results of an observational program for estimating the duration of bevacizumab therapy in patients with metastatic colorectal cancer in daily clinical practice
Poddubnaya I., Bobrovskaya E., Vladimirova L., Gordeev S., Davidenko I., Emelyanov S., Zharkova O., Koroleva I., Krasilnikova S., Maikoparova S., Malysheva T., Modestov A., Morozov A., Stachenko G., Strygina E., Tlish E., Feoktistova P., Chichkanova A., Sherman N.
卷 18, 编号 2 (2016) Predictive biomarkers in chemotherapy of pancreatic duct adenocarcinoma: rewiew of the literature PDF
(Rus)
Kovalenko Z., Kekeeva T., Lyadov V.
卷 11, 编号 3 (2009) Predoperatsionnaya (neoad\"yuvantnaya) endokrinoterapiya postmenopauzal'nykh bol'nykh rakom molochnoy zhelezy
Semiglazov V., Semiglazov V., Zhil'tsova E.
卷 20, 编号 1 (2018) Pre-operative chemoradiation therapy in complex treatment of patients with locally advanced tumors of the thoracic esophagus PDF
(Rus)
Shogenov M., Davydov M., Allakhverdiyev A., Chekini A., Filatov A., Akhmedov P., Serebryanskaya M., Korolyeva A., Dadyev I., Chichikov E., Grigorenko V., Kozlov N., Nazliyev P., Malikhova O., Tryakin A.
卷 21, 编号 3 (2019) The predictive value of digital mammography, breast ultrasound and their combination in the diagnosis of early breast cancer PDF
(Rus)
Alieva G., Korzhenkova G., Kolyadina I.
卷 13, 编号 4 (2011) Predstaviteli Rossiyskogo onkologicheskogosoobshchestva i Komiteta Soveta Federatsiipo sotsial'noy politike i zdravookhraneniyudogovorilis' sovmestno borot'sya s rakommolochnoy zhelezy v Rossii
- -.
卷 26, 编号 1 (2024) Benefits and limitations of breastfeeding for mothers with malignant tumors PDF
(Rus)
Ladodo O., Iurova M., Khokhlova S., Rodionov V., Sheshko E., Zubkov V., Makieva M., Chutkova D., Akhapkina E., Degtyarev D.
卷 4, 编号 3 (2002) Preimushchestva neoad\"yuvantnoy khimioterapii v lechenii ploskokletochnogo raka organov polosti rta i rotoglotki
Mudunov A., Matyakin E., Garin A., Podvyaznikov S., Azizyan R.
卷 16, 编号 1 (2014) Overcoming immunological tolerance is a way of treating malignant tumors: new perspectives
Samoilenko I., Kharkevich G., Demidov L.
卷 17, 编号 2 (2015) Preparat Gaziva® stanet dostupen‌‌ dlya terapii patsientov s khronicheskim limfotsitarnym leykozom
- -.
卷 6, 编号 2 (2004) Press-konferentsiya «Novye rezul'taty v endokrinnoy terapii raka molochnoy zhelezy»
- -.
卷 16, 编号 4 (2014) Press release
- -.
卷 10, 编号 3 (2008) Press-reliz Novaya era v lechenii raka pochki
- -.
卷 16, 编号 2 (2014) Press-release. «Merck Serono» announces new retrospective analysis shows significant clinical benefit in overall survival for metastatic colorectal cancer patients with RAS wild-type tumors receiving Erbitux® plus FOLFIRI
- -.
卷 16, 编号 2 (2014) Press-release. «Sanofi» makes a contribution in improving availability of treatment in women with breast cancer in Russia in accordance with international standards
- -.
卷 15, 编号 4 (2013) X russian conference with international participation «Malignant lymphomas», 24–25 October, 2013, Moscow
- -.
卷 11, 编号 4 (2009) Press-reliz V Tomske otkrylsya Tsentr ranney diagnostiki opukholey pecheni
- -.
卷 11, 编号 4 (2009) Press-reliz Glioblastoma: novye gorizonty lekarstvennoy terapii
- -.
卷 17, 编号 1 (2015) Press-reliz‌‌ «Novoe sozvezdie preparatov dlya lecheniya HER2-polozhitel'nogo raka molochnoy zhelezy»: satellitnyy simpozium kompanii «Rosh» v ramkakh bol'shoy konferentsii RUSSCO «Rak molochnoy zhelezy»
- -.
卷 17, 编号 5 (2015) Press release | October 21, 2015XII Annual Russian Conference with International Participation "Malignant Lymphomas" Symposium "New perspectives in the treatment of chronic lymphocytic leukemia"
- -.
卷 11, 编号 3 (2009) Press-reliz Vektibiks v kombinatsii s khimioterapiey v kachestve pervoy i vtoroy liniy terapii znachitel'no udlinyaet period bez progressirovaniya u bol'nykh metastaticheskim rakom tolstoy i pryamoy kishki.
- -.
卷 11, 编号 3 (2009) Press-reliz Evropeyskaya komissiya utverdila rasshirenie pokazaniy k primeneniyu Avastina, odobriv ego kombinatsiyus dotsetakselom v kachestve terapii 1-y linii dlya lecheniya rasprostranennogo (metastaticheskogo) raka molochnoy zhelezy
- -.
卷 11, 编号 3 (2009) Press-reliz Na IV Kongresse Rossiyskogo obshchestva onkourologov v Moskve obsudili targetnuyu terapiyu raka pochki i preimushchestva preparata Neksavar
- -.
卷 11, 编号 4 (2009) Press-reliz Na XIII Rossiyskom kongresse onkologov obsudili sostoyanie epidemiologicheskoy programmy skrininga HER2-statusa u zhenshchin, bol'nykh rakom molochnoy zhelezy (RMZh), a takzhe preimushchestvai perspektivy targetnoy terapii preparatami Gertseptin i Avastin
- -.
卷 11, 编号 3 (2009) Press-reliz Novoe protivoopukholevoe soedinenie regorafenib (BAY 73-4506) kompanii «Bayer» obespechilo stabilizatsiyu ili regressiyu u 81% bol'nykh rakom pochki
- -.
卷 10, 编号 3 (2008) Press-reliz Novye vozmozhnosti v lechenii raka pecheni
- -.
卷 16, 编号 3 (2014) Press Release. New data show Giotrif® (afatinib) provided more than one year additional survival for patients with lung cancer associated with the most common type of EGFR mutation (del19) compared to chemotherapy
- -.
卷 15, 编号 3 (2013) Press-reliz Preparat Avastin® odobren v Rossii dlya lecheniya patsientov s metastaticheskim kolorektal'nym rakom v 1 i 2-y liniyakh terapii nepreryvno
- -.
卷 16, 编号 1 (2014) Press-release. The resolution of oncologists of the North-West Federal District: screening for female reproductive system cancers is required
- -.
卷 16, 编号 4 (2014) Press releaseThe resolution of the expert council for targeted therapy of radioactive iodine-refractory differentiated thyroid cancer
- -.
卷 11, 编号 1 (2009) Press-reliz Targetnaya terapiya nemelkokletochnogo raka legkogo: nastoyashchee i budushchee
- -.
卷 11, 编号 1 (2009) Press-reliz Telemost prines radostnuyu vest'
- -.
卷 17, 编号 3 (2015) Press-release Combination treatment with Vargatef® and docetaxel contributes to statistically significant tumor reduction in patients with progressive adenocarcinoma of the lung in comparison with docetaxel in monotherapy
- -.
卷 11, 编号 2 (2009) Press-reliz44-e ezhegodnoe zasedanie Evropeyskoy assotsiatsii po izucheniyu pecheni (EASL)
- -.
卷 13, 编号 1 (2011) Press-relizEkspertnyy sovet Rossiyskogo obshchestva onkogematologovDiagnostika i lechenie bol'nykh khronicheskim limfoleykozom vysokogo riska
- -.
卷 11, 编号 3 (2009) Primenenie Aranozy pri neyroendokrinnykh opukholyakh
Gorbunova V., Orel N., Kuz'minov A.
卷 14, 编号 1 (2012) Primenenie belkov teplovogo shokav klinicheskoy onkologii
Shevtsov M., Khachatryan V., Margulis B.
卷 3, 编号 3 (2001) Primenenie G-KSF dlya immunoprofilaktiki gnoyno-septicheskikh oslozhneniy u onkologicheskikh bol'nykh posle obshirnykh khirurgicheskikh vmeshatel'stv
Nekhaev I., Sviridova S., Kiselevskiy M.
卷 26, 编号 4 (2024) Use of granulocyte colony-stimulating factors in patients with HIV-associated lymphoproliferative diseases receiving cytotoxic therapy: Experience of a research center PDF
(Rus)
Kremneva N., Dudina G., Tagieva E., Tokmakova A., Nemykin V.
卷 3, 编号 1 (2001) Primenenie dotsetaksela v lechenii sarkom myagkikh tkaney u detey
Protsenko R., Kolosov P., Prostomolotov O., Maschan A.
卷 6, 编号 3 (2004) Primenenie zomety v lechenii metastaticheskogo porazheniya skeleta (klinicheskiy opyt)
Aliev M., Bolotina L., Teplyakov V., Koroleva L., Karpenko V., Titov D.
卷 9, 编号 2 (2007) Primenenie Zomety na fone endokrinnoy terapii Femaroy u bol'nykh rakom molochnoy zhelezy s metastazami v kosti
Konstantinova M., Ovchinnikova L., Lomakin N., Galleev M., Neretina E., Mukhamedshina G., Mukhametgaleeva F.
卷 18, 编号 4 (2016) The use of PARP inhibitor - olaparib for the treatment of ovarian cancer in clinical practice PDF
(Rus)
Khokhlova S.
卷 12, 编号 1 (2010) Primenenie Iressy (gefitiniba)v kachestve terapii pervoy liniidlya lecheniya neoperabel'nykhadenokartsinom legkogo, soderzhashchikhmutatsiyu v gene EGFR
Moiseenko V., Protsenko S., Semenov I., Moiseenko F., Levchenko E., Matsko D., Ivantsov A., Ievleva A., Mityushkina N., Togo A., Imyanitov E.
卷 23, 编号 2 (2021) The use of atezolizumab in combination with chemotherapy in first-line of metastatic small cell lung cancer. Case report PDF
(Rus)
Ognerubov N., Antipova T.
卷 17, 编号 3 (2015) Primenenie kombinatsii ingibitorov BRAF i MEK u patsientov s BRAF+ metastaticheskoy melanomoy
Vakhabova Y.
卷 7, 编号 2 (2005) Primenenie kombinatsii navel'bina i kselody v terapii vtoroy linii metastaticheskogo raka molochnoy zhelezy
Kazantseva M., Davidenko I., Goncharova O., Mamaeva E.
卷 10, 编号 2 (2008) Primenenie kombinatsii T-VER u bol'nykhneseminomnymi germinogennymi opukholyami s plokhim prognozom: predvaritel'nye rezul'taty II fazy issledovaniya
Tryakin A., Tyulyandin S., Fedyanin M., Sergeev Y., Faynshteyn I., Polotskiy B., Figurin K., Zakharova T., Garin A.
卷 24, 编号 2 (2022) Combination therapy regimens in the treatment of metastatic renal cell carcinoma: A review PDF
(Rus)
Zukov R., Chernyaev D., Zulkaidarova A.
卷 8, 编号 1 (2006) Primenenie lenograstima (granotsit) v onkologii
Minenko S.
卷 4, 编号 3 (2002) Primenenie mabtery (rituksimaba) s antratsiklinosoderzhashchimi kombinatsiyami khimiopreparatov v kachestve pervoy linii lecheniya bol'nykh V-kletochnymi NKhL s neblagopriyatnym prognozom (predvaritel'nye rezul'taty)
Poddubnaya I., Kuril'nikov A., Osmanov D., Voznyy E., Borodkina A., Belonogov A.
卷 22, 编号 3 (2020) Use of nivolumab for colon cancer with Lynch syndrome PDF
(Rus)
Khakimov G., Tryakin A., Khakimova G.
卷 20, 编号 1 (2018) The use of low molecular weight heparin Enixum® in the prevention and treatment of thrombosis in oncology PDF
(Rus)
Somonova O., Elizarova A., Matveeva I.
卷 10, 编号 3 (2008) Primenenie nizkomolekulyarnykh geparinov dlya lecheniya ostrykh trombozov i tromboembolii legochnykh arteriyu onkologicheskikh bol'nykh
Somonova O., Madzhuga A., Elizarova A., Zubrikhina G.
卷 6, 编号 3 (2004) Primenenie preparata «Mikosist» dlya profilaktiki i lecheniya posttsitostaticheskikh gribkovykh oslozhneniy u bol'nykh limfoproliferativnymi zabolevaniyami
Fedorov A., Rukavitsyn O.
卷 9, 编号 4 (2007) Primenenie preparata Vero-Fludarabin v terapii limfoproliferativnykh zabolevaniy
Fedorov A., Rukavitsyn O.
卷 2, 编号 2 (2000) Primenenie preparata zofran u bol'nykh, poluchayushchikh tsitostaticheskuyu terapiyu
Bogdanova N.
卷 12, 编号 3 (2010) Primenenie preparata sorafenibpri lechenii gepatotsellyulyarnoy kartsinomy(Obzor klinicheskikh i neinterventsionnykhissledovaniy: issledovanie GIDEON)
Gorbunova V.
卷 21, 编号 2 (2019) The use of regorafenib in colorectal cancer PDF
(Rus)
Sekacheva M., Bagmet N., Guryanova A., Rashi D.
卷 18, 编号 3 (2016) Regorafenib application in patients with metastatic colorectal cancer in actual clinical practice PDF
(Rus)
Sekacheva M., Bagmet N.
卷 11, 编号 2 (2009) Primenenie selena v onkologii
Ognerubova I., Poddubnaya I.
卷 19, 编号 2 (2017) The application of oral transmucosal fentanyl for the treatment of breakthrough pain in cancer patients PDF
(Rus)
Nevzorova D., Kunyaeva T., Ibragimov A.
卷 10, 编号 2 (2008) Primenenie ftorafura v khimioterapii zlokachestvennykh opukholey
Platinskiy L., Bryuzgin V.
卷 10, 编号 2 (2008) Primenenie tsetuksimaba v lechenii ploskokletochnogo raka golovy i shei
Romanov I., Kupchan D.
卷 7, 编号 3 (2005) Primenenie eritropoetina posle vysokodoznoy khimioterapii s transplantatsiey autologichnykh gemopoeticheskikh kletok
Ptushkin V., Zhukov N., Minenko S.
卷 17, 编号 2 (2015) The illustration of the successful mobilization of hematopoietic stem cells using plerixafor and pegfilgrastim in the patient with non-hodgkin's lymphoma
Motalkina M., Kulyova S., Alexeev S., Zuzgin I., Filatova L., Zhabina A., Zverkova A., Ishmatova I., Rjazankina A., Artemyeva A., Semiglazova T.
卷 21, 编号 4 (2019) Principles of premetastatic niche formation PDF
(Rus)
Korneva Y., Ukrainets R.
卷 26, 编号 4 (2024) The reasons for prescribing antitumor drugs beyond the registered indications in real clinical practice: A retrospective study PDF
(Rus)
Karabina E., Sakaeva D., Lipatov О.
卷 15, 编号 2 (2013) Problem of iron-deficiency anemia in patients with cancers: practice in using iron-containing drugs
Snegovoy A.
卷 2, 编号 2 (2000) Problema osteoporoza i vozmozhnosti primeneniya miakal'tsika v onkologii
Makarenko N.
卷 9, 编号 2 (2007) Problema prodolzhitel'nosti zhizni bol'nykh zlokachestvennymi opukholyami, poluchayushchikh preparaty-stimulyatory eritropoeza
Pokataev I., Tyulyandin S.
751 - 900 的 1417 信息 << < 1 2 3 4 5 6 7 8 9 10 > >> 

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».